Table 2 Distribution of HLA-DRB1 alleles in the study population
From: Association of HLA-DRB1*11 and HLA-DRB1*12 gene polymorphism with COVID-19 in Burkina Faso
Clinical status | HLA-DRB1*11 | HLA-DRB1*12 | ||||||
|---|---|---|---|---|---|---|---|---|
n (%) | p-value | OR | 95% CI | n (%) | p-value | OR | 95% CI | |
CC- (n = 48) * | 4 (8.33) | 3 (6.25) | ||||||
CC+ (n = 38) | 13 (34.21) | 0.005 | 5.72 | [1.683–19.442] | 8 (21.05) | 0.054 | 4.00 | [0.981–16.302] |
SC+ (n = 52) | 9 (17.31) | 0.240 | 2.302 | [0.659–8.040] | 9 (17.31) | 0.089 | 3.140 | [0.796–12.378] |
NC+ (n = 60) | 12 (20.00) | 0.108 | 2.75 | [0.826–9.160] | 9 (15.00) | 0.150 | 2.65 | [0.675–10.383] |
Total (n = 198) | 38 (19.19) | 29 (14.65) | ||||||